LEADER 03476nam  22006855  450 
001 9910298355103321
005 20200704115347.0
010   $a1-4939-0261-X
024 7 $a10.1007/978-1-4939-0261-3
035   $a(CKB)3710000000089075
035   $a(EBL)1782005
035   $a(SSID)ssj0001185883
035   $a(PQKBManifestationID)11766239
035   $a(PQKBTitleCode)TC0001185883
035   $a(PQKBWorkID)11209728
035   $a(PQKB)10967457
035   $a(MiAaPQ)EBC1782005
035   $a(DE-He213)978-1-4939-0261-3
035   $a(PPN)176750053
035   $a(EXLCZ)993710000000089075
100   $a20140227d2014      u|         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aClinical Applications of Botulinum Neurotoxin /$fedited by Keith A. Foster
205   $a1st ed. 2014.
210  1$aNew York, NY :$cSpringer New York :$cImprint: Springer,$d2014.
215   $a1 online resource (201 p.)
225 1 $aCurrent Topics in Neurotoxicity,$x2363-9563 ;$v5
300   $aDescription based upon print version of record.
311   $a1-322-13268-2 
311   $a1-4939-0260-1 
320   $aIncludes bibliographical references at the end of each chapters and index.
327   $aBotulinum Toxin as a Clinical Product -- Clinical Use of Botulinum Neurotoxin: Neuromuscular Disorders -- Clinical Use of Botulinum Neurotoxin: Autonomic Conditions -- Clinical Use of Botulinum Neurotoxin: Urogenital Disorders Including Overactive Bladder -- Clinical Use of Botulinum Neurotoxins: Pain -- Future Developments: Engineering the Neurotoxin. .
330   $aCurrently, there are tremendous advances being made in understanding the basic science of both the structure and function of botulinum neurotoxins. This knowledge is opening up opportunities in regard to both therapeutic uses and treatment and protection options for civil and bio-defense applications. This volume fully evaluates the status of neurotoxin research and exploitation, with a focus on clinical application. The book is a multi-authored collection of chapters written by the leading authorities responsible for the current scientific and clinical research that is advancing the understanding and exploitation of the neurotoxins, and is both up to date and authoritative.
410  0$aCurrent Topics in Neurotoxicity,$x2363-9563 ;$v5
606   $aMolecular biology
606   $aPharmacology
606   $aMedicine
606   $aNeurosciences
606   $aMolecular Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/B1700X
606   $aPharmacology/Toxicology$3https://scigraph.springernature.com/ontologies/product-market-codes/B21007
606   $aBiomedicine, general$3https://scigraph.springernature.com/ontologies/product-market-codes/B0000X
606   $aNeurosciences$3https://scigraph.springernature.com/ontologies/product-market-codes/B18006
615  0$aMolecular biology.
615  0$aPharmacology.
615  0$aMedicine.
615  0$aNeurosciences.
615 14$aMolecular Medicine.
615 24$aPharmacology/Toxicology.
615 24$aBiomedicine, general.
615 24$aNeurosciences.
676   $a615.95293
702   $aFoster$b Keith A$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910298355103321
996   $aClinical Applications of Botulinum Neurotoxin$92539489
997   $aUNINA